Molecularis GmbH

Molecularis GmbH is launching as a specialized molecular and microbiological contract laboratory on January 1, 2025. The company offers comprehensive services in two main areas: In vitro and ex vivo toxicology testing, e.g. analysis of chemical, drug, pharmaceutical, cosmetic, and ingredient effects on: • Isolated cells • 3D skin models • Microorganisms Microbiological services: • Minimal inhibitory concentration assays (MIC, MBC, MFC), and viability tests • Great expertise in bacterial co-cultures depending on the habitat As a partner for innovative research, Molecularis GmbH aims to support clients in product research and development. The company emphasizes its dedication to precise scientific analysis and innovative solutions, positioning itself as a reliable partner for exciting projects in the field of molecular and microbiological contract research. Key Features: Specialized Focus: Molecular and microbiological contract laboratory Toxicology Expertise: In vitro and ex vivo testing capabilities Microbiological Proficiency: Comprehensive bacterial research services Innovation-Driven: Support for research and development of new products Dedicated Team: Committed to precise analysis and innovative solutions